by Brindle, Kevin M, Izquierdo-García, José L, Lewis, David Y, Mair, Richard J and Wright, Alan J
Abstract:
Modern imaging techniques, particularly functional imaging techniques that interrogate some specific aspect of underlying tumor biology, have enormous potential in neuro-oncology for disease detection, grading, and tumor delineation to guide biopsy and resection; monitoring treatment response; and targeting radiotherapy. This brief review considers the role of magnetic resonance imaging and spectroscopy, and positron emission tomography in these areas and discusses the factors that limit translation of new techniques to the clinic, in particular, the cost and difficulties associated with validation in multicenter clinical trials.
Reference:
Brain Tumor Imaging. (Brindle, Kevin M, Izquierdo-García, José L, Lewis, David Y, Mair, Richard J and Wright, Alan J), In Journal of clinical oncology : official journal of the American Society of Clinical Oncology, volume 35, 2017.
Bibtex Entry:
@article{Brindle:2017ic,
author = {Brindle, Kevin M and Izquierdo-Garc{'i}a, Jos{'e} L and Lewis, David Y and Mair, Richard J and Wright, Alan J},
title = {{Brain Tumor Imaging.}},
journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
year = {2017},
volume = {35},
number = {21},
pages = {2432--2438},
month = jul,
affiliation = {Kevin M. Brindle, Richard J. Mair, and Alan J. Wright, Cancer Research UK Cambridge Institute, Cambridge; David Y. Lewis, Cancer Research UK Beatson Institute, Glasgow, United Kingdom; Jos{'e} L. Izquierdo-Garc{'i}a, Fundaci{'o}n Centro Nacional de Investigaciones Cardiovasculares Carlos III and Centro de Investigaci{'o}n Biom{'e}dica en Red Enfermedades Respiratorias, Madrid, Spain.},
doi = {10.1200/JCO.2017.72.7636},
pmid = {28640699},
language = {English},
rating = {0},
date-added = {2018-03-16T12:39:53GMT},
date-modified = {2018-06-17T18:05:23GMT},
abstract = {Modern imaging techniques, particularly functional imaging techniques that interrogate some specific aspect of underlying tumor biology, have enormous potential in neuro-oncology for disease detection, grading, and tumor delineation to guide biopsy and resection; monitoring treatment response; and targeting radiotherapy. This brief review considers the role of magnetic resonance imaging and spectroscopy, and positron emission tomography in these areas and discusses the factors that limit translation of new techniques to the clinic, in particular, the cost and difficulties associated with validation in multicenter clinical trials.},
url = {http://ascopubs.org/doi/10.1200/JCO.2017.72.7636},
uri = {url{papers3://publication/doi/10.1200/JCO.2017.72.7636}}
}